Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Jefferies Financial
JEF
5
Amazon
AMZN
AU Stock MarketDetailed Quotes
TYP Tryptamine Therapeutics Ltd
- 0.038
- +0.001+2.70%
20min DelayMarket Closed May 15 16:00 AET
54.68MMarket Cap-0.42P/E (Static)
0.038High0.036Low2.20MVolume0.038Open0.037Pre Close82.84KTurnover0.05752wk High0.25%Turnover Ratio1.44BShares0.01752wk Low-0.038EPS TTM33.68MFloat Cap0.057Historical HighLossP/E (Static)886.43MShs Float0.017Historical Low-0.091EPS LYR5.41%Amplitude--Dividend TTM12.67P/B1Lot Size--Div YieldTTM
About Tryptamine Therapeutics Ltd Company
Tryptamine Therapeutics Ltd is a clinical-stage biotechnology company focused on bringing transformative medicine with known safety profiles to diseases with no effective first-line treatments. The programs are designed to address neuropsychiatric disorders through the therapeutic dosing of synthetic psilocybin and IV infused psilocin in conjunction with psychotherapy. Its product pipeline includes TRP-8803 (IV-infused psilocin) and TRP-8802 (oral psilocybin).
Company Profile
SymbolTYP
Company NameTryptamine Therapeutics Ltd
Founded2013
MarketASX
Employees50
Fiscal Year Ends06-30
AddressC/o Bio101 Financial Advisory Pty Ltd 697 Burke Road, Suite 201
CityMelbourne
CountryAustralia
Zip Code3124
Phone+61 390920475
Share RegistryAUTOMIC REGISTRY SERVICES
Level 5, 126 Phillip Street, SYDNEY, NSW, AUSTRALIA, 2000
02 9698 5414
Company Executives
- Name
- Position
- Salary
- Peter Molloy
- Chief Business Officer and Executive Director,Non-Executive Director
- --
- Mark Davies
- Non-Executive Chairman,Non-Executive Director
- --
- Jason Carroll
- Non-Executive Director
- --
- Gage Jull
- Non-Executive Director
- --
- Clarke Barlow
- Non-Executive Director
- --
- Christopher Ntoumenopoulos
- Non-Executive Director
- --
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting